M. Ross Johnson
Direttore/Membro del Consiglio presso Nuada Pharmaceuticals, Inc.
Profilo
M.
Ross Johnson is currently a Director at Nuada Pharmaceuticals, Inc. and a Director-Education Advancement Board at The University of North Carolina at Charlotte.
He was formerly the Chairman at Mast Therapeutics, Inc. from 2002 to 2007, an Independent Director at RespireRx Pharmaceuticals, Inc. from 2011 to 2013, and the President, Chief Executive & Scientific Officer at Trimeris, Inc. from 1995 to 1999.
He was also a Member-Governors Board at Research Triangle Institute, a Principal at Pfizer Central Research, and the Vice President-Chemistry at Glaxo, Inc. from 1987 to 1994.
Johnson received his undergraduate degree from the University of California, Berkeley and his doctorate from the University of California, Santa Barbara.
Posizioni attive di M. Ross Johnson
Società | Posizione | Inizio |
---|---|---|
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Direttore/Membro del Consiglio | - |
The University of North Carolina at Charlotte | Corporate Officer/Principal | 16/06/2011 |
Precedenti posizioni note di M. Ross Johnson
Società | Posizione | Fine |
---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 22/03/2013 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Presidente | 06/03/2007 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Presidente | 01/01/1999 |
Glaxo, Inc. | Corporate Officer/Principal | 01/01/1994 |
Pfizer Central Research | Corporate Officer/Principal | - |
Formazione di M. Ross Johnson
University of California, Berkeley | Undergraduate Degree |
University of California, Santa Barbara | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
Aziende private | 6 |
---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Glaxo, Inc. | |
Research Triangle Institute
Research Triangle Institute Miscellaneous Commercial ServicesCommercial Services Research Triangle Institute is a non-profit organization which provides research and development services. It offers surveys and data collection, statistics and data science, assessment and analysis, program design and implementation, and research technologies and analytical laboratory. The company was founded in 1958 and is headquartered in Research Triangle Park, NC. | Commercial Services |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Health Technology |
Pfizer Central Research |
- Borsa valori
- Insiders
- M. Ross Johnson